Insider · CIK 0001816160

Kihara James

CIK 0001816160 Name as filed on the most recent filing

Filed as Kihara James (25)

29 transaction lines · from 25 filings · filed 2022-02-25 to 2026-06-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

29 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-26 S, Open-market sale Acadia Pharmaceuticals IncACAD 297,912, disposed Open Form 4 filing 0001816160-26-000009
2026-05-26 S, Open-market sale Acadia Pharmaceuticals IncACAD 114,393, disposed Open Form 4 filing 0001816160-26-000008
2026-05-04 S, Open-market sale Acadia Pharmaceuticals IncACAD 29,024, disposed Open Form 4 filing 0001816160-26-000007
2026-04-07 S, Open-market sale Acadia Pharmaceuticals IncACAD 22,866, disposed Open Form 4 filing 0001816160-26-000005
2026-03-26 S, Open-market sale Acadia Pharmaceuticals IncACAD 2 lines 24,011, disposed Open Form 4 filing 0001816160-26-000003
2026-03-25 S, Open-market sale Acadia Pharmaceuticals IncACAD 17,885, disposed Open Form 4 filing 0001816160-26-000003
2025-11-18 S, Open-market sale Acadia Pharmaceuticals IncACAD 96,754, disposed Open Form 4 filing 0001816160-25-000004
2025-05-16 S, Open-market sale Acadia Pharmaceuticals IncACAD 2 lines 90,000, disposed Open Form 4 filing 0001415889-25-013742
2025-05-02 S, Open-market sale Acadia Pharmaceuticals IncACAD 19,374, disposed Open Form 4 filing 0001415889-25-011875
2025-04-08 S, Open-market sale Acadia Pharmaceuticals IncACAD 15,235, disposed Open Form 4 filing 0001415889-25-010423
2025-03-26 S, Open-market sale Acadia Pharmaceuticals IncACAD 18,670, disposed Open Form 4 filing 0001415889-25-009075
2025-02-24 S, Open-market sale Acadia Pharmaceuticals IncACAD 9,481, disposed Open Form 4 filing 0001415889-25-005575
2024-11-19 S, Open-market sale Acadia Pharmaceuticals IncACAD 68,467, disposed Open Form 4 filing 0001415889-24-027293
2024-05-02 S, Open-market sale Acadia Pharmaceuticals IncACAD 22,462, disposed Open Form 4 filing 0001415889-24-012236
2024-04-08 S, Open-market sale Acadia Pharmaceuticals IncACAD 2 lines 31,987, disposed Open Form 4 filing 0001415889-24-010602
2024-02-26 S, Open-market sale Acadia Pharmaceuticals IncACAD 11,694, disposed Open Form 4 filing 0001415889-24-005574
2023-12-15 S, Open-market sale Acadia Pharmaceuticals IncACAD 56,600, disposed Open Form 4 filing 0001209191-23-058891
2023-11-20 S, Open-market sale Acadia Pharmaceuticals IncACAD 44,940, disposed Open Form 4 filing 0001209191-23-056354
2023-09-15 S, Open-market sale Acadia Pharmaceuticals IncACAD 51,760, disposed Open Form 4 filing 0001209191-23-050072
2023-06-15 S, Open-market sale Acadia Pharmaceuticals IncACAD 48,300, disposed Open Form 4 filing 0001209191-23-037932
2023-05-17 S, Open-market sale Acadia Pharmaceuticals IncACAD 133,808, disposed Open Form 4 filing 0001209191-23-031245
2023-04-10 S, Open-market sale Acadia Pharmaceuticals IncACAD 9,487, disposed Open Form 4 filing 0001209191-23-024061
2023-04-06 S, Open-market sale Acadia Pharmaceuticals IncACAD 12,730, disposed Open Form 4 filing 0001209191-23-023864
2023-02-24 S, Open-market sale Acadia Pharmaceuticals IncACAD 6,573, disposed Open Form 4 filing 0001209191-23-013471
2022-04-08 S, Open-market sale Acadia Pharmaceuticals IncACAD 27,726, disposed Open Form 4 filing 0001209191-22-024064
2022-02-23 S, Open-market sale Acadia Pharmaceuticals IncACAD 8,544, disposed Open Form 4 filing 0001209191-22-013286

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 29
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kihara James, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001816160

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.